Acadia Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAcadia Pharmaceuticals

Acadia Pharmaceuticals(ACAD)

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Nuplazid	Pimavanserin	2016-04-29	2024-2038	Parkinson disease , Hallucinations , Schizophrenia spectrum and other psychotic disorders
Daybue	Trofinetide	2023-03-10	2032-2040	Rett syndrome

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

traumatic brain injuries

,

brain concussion

,

post-concussion syndrome

,

fragile x syndrome

,

,

Fluorodopa f-18

multiple myeloma

,

castration-resistant prostatic neoplasms

,

,

prostatic neoplasms

,

relapsing-remitting multiple sclerosis

,

diabetes mellitus

,

type 1 diabetes mellitus

,

healthy volunteers/patients

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

non-small-cell lung carcinoma

,

atrial fibrillation

,

prader-willi syndrome

,

,

postpartum hemorrhage

,

,

obstetric labor complications

,

uterine inertia

prostatic hyperplasia

,

healthy volunteers/patients

,

,

respiratory tract diseases

,

respiration disorders

,

,

kidney diseases

,

,

,

,

,

respiratory tract infections

,

,

premature obstetric labor

,

,

pulmonary edema

,

,

bacterial infections

,

,

hepatic insufficiency

,

,

,

multiple myeloma

,

,

plasma cell neoplasms

,

breast neoplasms

,

,

,

atherosclerosis

,

obstructive lung diseases

,

,

pancreatic neoplasms

,

,

follicular lymphoma

,

allergic rhinitis

,

pulmonary tuberculosis

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

sjogren's syndrome

,

,

,

,

,

,

systemic lupus erythematosus

,

,

acquired immunodeficiency syndrome

,

,

type 2 diabetes mellitus

,

human influenza

,

communicable diseases

,

,

,

parkinson disease

,

,

migraine disorders

,

,

major depressive disorder

,

depressive disorder

,

churg-strauss syndrome

,

granulomatosis with polyangiitis

,

systemic vasculitis

,

eosinophilic granuloma

,

neisseria meningitidis

,

haemophilus influenzae type b

,

restless legs syndrome

,

psychomotor agitation

,

,

,

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

respiratory syncytial virus infections

,

,

chronic obstructive pulmonary disease

,

,

diabetes mellitus

,

,

,

,

pulmonary eosinophilia

,

prostatic neoplasms

,

,

growth and development

,

,

,

postherpetic neuralgia

,

,

psychotic disorders

Fludeoxyglucose f-18

colorectal neoplasms

,

mucinous adenocarcinoma

,

colonic neoplasms

,

,

rectal neoplasms

,

cystadenocarcinoma

,

parkinson disease

,

multiple sclerosis

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use